These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 24281063)

  • 1. The Chemoimmunotherapy Revolution in Resectable NSCLC-The Times They Are A-Changin'.
    Rolfo C; Russo A
    JAMA Oncol; 2024 May; 10(5):569-570. PubMed ID: 38512287
    [No Abstract]   [Full Text] [Related]  

  • 2. Locally Advanced Relapse May Not Be Equal to Stage 3 Non-Small Cell Lung Cancer-Reply.
    Tachihara M; Tsujino K
    JAMA Oncol; 2024 Jun; 10(6):829-830. PubMed ID: 38573628
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognosis of patients with recurrent nonsmall cell lung cancer who received the best supportive care alone.
    Sonoda D; Kondo Y; Maruyama R; Naito M; Mikubo M; Shiomi K; Satoh Y
    Curr Probl Surg; 2024 Jan; 61(1):101429. PubMed ID: 38161060
    [No Abstract]   [Full Text] [Related]  

  • 4. Lung cancer in 2014: optimizing lung cancer treatment approaches.
    Rosell R; Karachaliou N
    Nat Rev Clin Oncol; 2015 Feb; 12(2):75-6. PubMed ID: 25533943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response and acquired resistance to everolimus in anaplastic thyroid cancer.
    Wagle N; Grabiner BC; Van Allen EM; Amin-Mansour A; Taylor-Weiner A; Rosenberg M; Gray N; Barletta JA; Guo Y; Swanson SJ; Ruan DT; Hanna GJ; Haddad RI; Getz G; Kwiatkowski DJ; Carter SL; Sabatini DM; Jänne PA; Garraway LA; Lorch JH
    N Engl J Med; 2014 Oct; 371(15):1426-33. PubMed ID: 25295501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-penetration and antitumor efficacy of cetuximab are enhanced by co-administered iRGD in a murine model of human NSCLC.
    Zhang Y; Yang J; Ding M; Li L; Lu Z; Zhang Q; Zheng J
    Oncol Lett; 2016 Nov; 12(5):3241-3249. PubMed ID: 27899989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of aerosol therapy of lung cancer correlates with EGFR paralysis induced by AvidinOX-anchored biotinylated Cetuximab.
    De Santis R; Rosi A; Anastasi AM; Chiapparino C; Albertoni C; Leoni B; Pelliccia A; Santapaola D; Carollo V; Marra E; Aurisicchio L; Arseni B; Pacello ML; Palmieri G; Battella S; Petronzelli F; Milazzo FM
    Oncotarget; 2014 Oct; 5(19):9239-55. PubMed ID: 25238453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of non-small-cell lung carcinoma: PS2 patients' particularities].
    Deppermann KM
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S31-4S34. PubMed ID: 15687991
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung cancer: cetuximab, you're fired.
    Villanueva MT
    Nat Rev Clin Oncol; 2014 Jan; 11(1):3. PubMed ID: 24281063
    [No Abstract]   [Full Text] [Related]  

  • 10. Cetuximab and non-small-cell lung cancer: end of the story?
    Rossi A
    Lancet Oncol; 2013 Dec; 14(13):1251-3. PubMed ID: 24231626
    [No Abstract]   [Full Text] [Related]  

  • 11. Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial.
    Kim ES; Neubauer M; Cohn A; Schwartzberg L; Garbo L; Caton J; Robert F; Reynolds C; Katz T; Chittoor S; Simms L; Saxman S
    Lancet Oncol; 2013 Dec; 14(13):1326-36. PubMed ID: 24231627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy in stage III non-small cell lung cancer.
    Eberhardt WE; Hepp R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
    [No Abstract]   [Full Text] [Related]  

  • 13. [Second-line chemotherapy in non-small-cell lung cancer].
    Schütte W
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S13-4S16. PubMed ID: 15687987
    [No Abstract]   [Full Text] [Related]  

  • 14. A phase II study of the combination of docetaxel and bevacizumab for previously treated non-small cell lung cancer.
    Shimizu T; Nakagawa Y; Asai Y; Tsujino I; Takahashi N; Gon Y
    J Int Med Res; 2019 Jul; 47(7):3079-3087. PubMed ID: 31179803
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.